Related Experiment Video
Updated: Jul 8, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4
Zhuoshi Li1,2, Shiqing Wang1,2, Tao Guo1,2
1Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116044, China.
Abstract:
Metastasis-associated in colon cancer-1 (MACC1) was identified as a new player in lung cancer development, and some stemness-related genes can be novel transcriptional targets of MACC1. Cancer stem cells (CSCs) are responsible for sustaining tumorigenesis and plasticity. Both CSCs and non-CSCs are plastic and capable of undergoing phenotypic transition, especially the dedifferentiation of non-CSCs switch to CSC-like cells. However, the precise role of MACC1 during this process is largely unknown. Here, we showed that MACC1 promoted the transition from non-CSC to CSC in lung cancer. We found MACC1 was overexpressed in stemness enriched cells, enhancing the transition from no-CSCs to CSCs, while short-hairpin RNA-mediated Knockdown of MACC1 impaired this process. High-throughput sequencing and tumor specimen analysis revealed that MACC1 was negative correlated with Krüppel-like factor 4 (KLF4) expression level, which acts as a negative stemness regulator in lung cancer. Mechanistically, MACC1 delays the degradation of KLF4 mRNA by repressing the expression of microRNA-25, thereby promoting the KLF4 mRNA stabilization at the post-transcriptional level. Collectively, our findings may facilitate efforts to promote the development of precision targeted therapy for cancer stem cells in lung cancer.
Insights
Metastasis-associated in colon cancer-1 (MACC1) promotes lung cancer stem cell (CSC) development by stabilizing Krüppel-like factor 4 (KLF4) mRNA. This study reveals MACC1
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cancer stem cells (CSCs) drive tumor growth and plasticity.
- Non-CSCs can dedifferentiate into CSC-like cells.
- The role of MACC1 in this transition is unclear.
Purpose of the Study:
- Investigate MACC1's role in non-CSC to CSC transition in lung cancer.
- Identify MACC1's molecular mechanisms regulating stemness.
- Explore MACC1 as a therapeutic target for CSCs.
Main Methods:
- Overexpression and knockdown studies of MACC1.
- High-throughput sequencing.
- Analysis of lung tumor specimens.
- MicroRNA expression analysis.
Main Results:
- MACC1 overexpression enhanced non-CSC to CSC transition.
- MACC1 knockdown inhibited this transition.
- MACC1 negatively correlated with KLF4 expression.
- MACC1 repressed miR-25, stabilizing KLF4 mRNA.
Conclusions:
- MACC1 promotes lung cancer stemness by post-transcriptionally regulating KLF4.
- MACC1 is a potential therapeutic target for lung CSCs.
- Understanding MACC1-KLF4 interaction is key for precision therapy.

